Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Patent Expiration
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate was first introduced by Teva Womens Health Inc
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Patents
Given below is the list of patents protecting Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Adderall 10 | US6384020 | Rapid immediate release oral dosage form |
Jul 06, 2020
(Expired) | Teva Womens |
| Adderall 10 |
US6384020 (Pediatric) | Rapid immediate release oral dosage form |
Jan 06, 2021
(Expired) | Teva Womens |
| Adderall 12.5 | US6384020 | Rapid immediate release oral dosage form |
Jul 06, 2020
(Expired) | Teva Womens |
| Adderall 12.5 |
US6384020 (Pediatric) | Rapid immediate release oral dosage form |
Jan 06, 2021
(Expired) | Teva Womens |
| Adderall 15 | US6384020 | Rapid immediate release oral dosage form |
Jul 06, 2020
(Expired) | Teva Womens |
| Adderall 15 |
US6384020 (Pediatric) | Rapid immediate release oral dosage form |
Jan 06, 2021
(Expired) | Teva Womens |
| Adderall 20 | US6384020 | Rapid immediate release oral dosage form |
Jul 06, 2020
(Expired) | Teva Womens |
| Adderall 20 |
US6384020 (Pediatric) | Rapid immediate release oral dosage form |
Jan 06, 2021
(Expired) | Teva Womens |
| Adderall 30 | US6384020 | Rapid immediate release oral dosage form |
Jul 06, 2020
(Expired) | Teva Womens |
| Adderall 30 |
US6384020 (Pediatric) | Rapid immediate release oral dosage form |
Jan 06, 2021
(Expired) | Teva Womens |
| Adderall 5 | US6384020 | Rapid immediate release oral dosage form |
Jul 06, 2020
(Expired) | Teva Womens |
| Adderall 5 |
US6384020 (Pediatric) | Rapid immediate release oral dosage form |
Jan 06, 2021
(Expired) | Teva Womens |
| Adderall 7.5 | US6384020 | Rapid immediate release oral dosage form |
Jul 06, 2020
(Expired) | Teva Womens |
| Adderall 7.5 |
US6384020 (Pediatric) | Rapid immediate release oral dosage form |
Jan 06, 2021
(Expired) | Teva Womens |
| Adderall Xr 10 | US6322819 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 10 |
US6322819 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 10 | US6605300 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 10 |
US6605300 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 10 | USRE41148 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 10 |
USRE41148 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 10 | USRE42096 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 10 |
USRE42096 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 | US6322819 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 |
US6322819 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 | US6605300 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 |
US6605300 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 | USRE41148 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 |
USRE41148 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 | USRE42096 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 15 |
USRE42096 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 | US6322819 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 |
US6322819 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 | US6605300 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 |
US6605300 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 | USRE41148 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 |
USRE41148 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 | USRE42096 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 20 |
USRE42096 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 | US6322819 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 |
US6322819 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 | US6605300 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 |
US6605300 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 | USRE41148 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 |
USRE41148 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 | USRE42096 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 25 |
USRE42096 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 | US6322819 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 |
US6322819 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 | US6605300 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 |
US6605300 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 | USRE41148 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 |
USRE41148 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 | USRE42096 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 30 |
USRE42096 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 | US6322819 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 |
US6322819 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 | US6605300 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 |
US6605300 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 | USRE41148 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 |
USRE41148 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 | USRE42096 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Adderall Xr 5 |
USRE42096 (Pediatric) | Oral pulsed dose drug delivery system |
Apr 21, 2019
(Expired) | Takeda Pharms Usa |
| Mydayis | US6913768 | Sustained release delivery of amphetamine salts |
May 24, 2023
(Expired) | Takeda Pharms Usa |
| Mydayis | US8846100 | Controlled dose drug delivery system | Aug 24, 2029 | Takeda Pharms Usa |
| Mydayis | US9173857 | Controlled dose drug delivery system | May 12, 2026 | Takeda Pharms Usa |
| Mydayis | USRE41148 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
| Mydayis | USRE42096 | Oral pulsed dose drug delivery system |
Oct 21, 2018
(Expired) | Takeda Pharms Usa |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Generics
Several generic applications have been filed for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. The first generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate was by Barr Laboratories Inc and was approved on Feb 11, 2002. And the latest generic version is by Alkem Laboratories Ltd and was approved on Oct 6, 2023.
Given below is the list of companies who have filed for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate generic.
1. AUROLIFE PHARMA LLC
Aurolife Pharma Llc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Aurolife Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 24, 2020 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 24, 2020 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 24, 2020 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Nov 27, 2013 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 24, 2020 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Nov 27, 2013 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 24, 2020 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 24, 2020 |
2. BARR
Barr Laboratories Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Barr.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG
(reference standard) | tablet | Prescription | ORAL | AB | Feb 11, 2002 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Feb 11, 2002 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Feb 11, 2002 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Feb 11, 2002 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Mar 19, 2003 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Mar 19, 2003 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Mar 19, 2003 |
3. TEVA
Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 29, 2013 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 29, 2013 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 29, 2013 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 29, 2013 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 29, 2013 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 29, 2013 |
4. IMPAX LABS
Impax Laboratories Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Impax Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | Feb 16, 2016 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Prescription | ORAL | AB1 | Feb 16, 2016 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Prescription | ORAL | AB1 | Feb 16, 2016 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Prescription | ORAL | AB1 | Feb 16, 2016 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Prescription | ORAL | AB1 | Feb 16, 2016 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Prescription | ORAL | AB1 | Feb 16, 2016 |
5. LANNETT CO INC
Lannett Co Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Jul 8, 2022 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Jul 8, 2022 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Jul 8, 2022 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Jul 8, 2022 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | Nov 26, 2021 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Jul 8, 2022 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Jul 8, 2022 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Jul 8, 2022 |
6. NUVO PHARM
Nuvo Pharmaceutical Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Nuvo Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Dec 28, 2017 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Dec 28, 2017 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Dec 28, 2017 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Dec 28, 2017 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Dec 28, 2017 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Dec 28, 2017 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Dec 28, 2017 |
7. NESHER PHARMS
Nesher Pharmaceuticals Usa Llc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Nesher Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Discontinued | ORAL | N/A | Jul 17, 2019 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Discontinued | ORAL | N/A | Jul 17, 2019 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Discontinued | ORAL | N/A | Jul 17, 2019 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Discontinued | ORAL | N/A | Jul 17, 2019 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Discontinued | ORAL | N/A | Jul 17, 2019 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Discontinued | ORAL | N/A | Jul 17, 2019 |
8. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB2 | Sep 27, 2023 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | capsule, extended release | Prescription | ORAL | AB2 | Sep 27, 2023 |
| 12.5MG; 12.5MG; 12.5MG; 12.5MG | capsule, extended release | Prescription | ORAL | AB2 | Sep 27, 2023 |
| 9.375MG; 9.375MG; 9.375MG; 9.375MG | capsule, extended release | Prescription | ORAL | AB2 | Sep 27, 2023 |
9. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | capsule, extended release | Prescription | ORAL | AB2 | Jan 31, 2022 |
| 12.5MG; 12.5MG; 12.5MG; 12.5MG | capsule, extended release | Prescription | ORAL | AB2 | Jan 31, 2022 |
| 9.375MG; 9.375MG; 9.375MG; 9.375MG | capsule, extended release | Prescription | ORAL | AB2 | Jan 31, 2022 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB2 | Jan 31, 2022 |
10. ELITE LABS INC
Elite Laboratories Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Elite Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Prescription | ORAL | AB1 | Dec 11, 2019 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Dec 7, 2018 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Prescription | ORAL | AB1 | Dec 11, 2019 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Dec 7, 2018 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Prescription | ORAL | AB1 | Dec 11, 2019 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Prescription | ORAL | AB1 | Dec 11, 2019 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Prescription | ORAL | AB1 | Dec 11, 2019 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | Dec 11, 2019 |
11. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
12. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Feb 5, 2016 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Feb 5, 2016 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Feb 5, 2016 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Feb 5, 2016 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | Jun 22, 2012 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Feb 5, 2016 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Feb 5, 2016 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Feb 5, 2016 |
13. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Discontinued | ORAL | N/A | Nov 22, 2021 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Discontinued | ORAL | N/A | Nov 22, 2021 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Discontinued | ORAL | N/A | Nov 22, 2021 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Discontinued | ORAL | N/A | Nov 22, 2021 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Discontinued | ORAL | N/A | Nov 22, 2021 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Discontinued | ORAL | N/A | Nov 22, 2021 |
| 5MG; 5MG; 5MG; 5MG | tablet | Discontinued | ORAL | N/A | Nov 22, 2021 |
14. SPECGX LLC
Specgx Llc has filed for 10 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Specgx Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | capsule, extended release | Prescription | ORAL | AB2 | Aug 31, 2023 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Prescription | ORAL | AB1 | Apr 22, 2019 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Oct 7, 2003 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Prescription | ORAL | AB1 | Apr 22, 2019 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Prescription | ORAL | AB1 | Apr 22, 2019 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Prescription | ORAL | AB1 | Apr 22, 2019 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Prescription | ORAL | AB1 | Apr 22, 2019 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB2 | Aug 31, 2023 |
| 9.375MG; 9.375MG; 9.375MG; 9.375MG | capsule, extended release | Prescription | ORAL | AB2 | Aug 31, 2023 |
| 12.5MG; 12.5MG; 12.5MG; 12.5MG | capsule, extended release | Prescription | ORAL | AB2 | Aug 31, 2023 |
15. SANDOZ
Sandoz Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Jun 14, 2002 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Jun 14, 2002 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Jun 14, 2002 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Sep 27, 2002 |
16. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Prescription | ORAL | AB1 | May 17, 2019 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Prescription | ORAL | AB1 | May 17, 2019 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Prescription | ORAL | AB1 | May 17, 2019 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Sep 9, 2003 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Prescription | ORAL | AB1 | May 17, 2019 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Sep 9, 2003 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Prescription | ORAL | AB1 | May 17, 2019 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | May 17, 2019 |
17. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Prescription | ORAL | AB1 | Sep 29, 2021 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Apr 22, 2021 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Prescription | ORAL | AB1 | Sep 29, 2021 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Prescription | ORAL | AB1 | Sep 29, 2021 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Prescription | ORAL | AB1 | Sep 29, 2021 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Prescription | ORAL | AB1 | Sep 29, 2021 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Apr 22, 2021 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | Sep 29, 2021 |
18. ALVOGEN
Alvogen Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Alvogen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Jul 28, 2017 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Jul 28, 2017 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Jul 28, 2017 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Jul 28, 2017 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Jul 28, 2017 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Jul 28, 2017 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Jul 28, 2017 |
19. CEDIPROF INC
Cediprof Inc has filed for 5 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Cediprof Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Discontinued | ORAL | N/A | Jul 5, 2022 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 5, 2022 |
| 5MG; 5MG; 5MG; 5MG | tablet | Discontinued | ORAL | N/A | Jul 5, 2022 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Discontinued | ORAL | N/A | Jul 5, 2022 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Discontinued | ORAL | N/A | Jul 5, 2022 |
20. RHODES PHARMS
Rhodes Pharmaceuticals Lp has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Rhodes Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Jan 13, 2021 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Jan 13, 2021 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Jan 13, 2021 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Jan 13, 2021 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | May 17, 2019 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Jan 13, 2021 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Jan 13, 2021 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Jan 13, 2021 |
21. MYLAN
Mylan Pharmaceuticals Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Discontinued | ORAL | N/A | Nov 10, 2015 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Discontinued | ORAL | N/A | Nov 10, 2015 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Discontinued | ORAL | N/A | Nov 10, 2015 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Discontinued | ORAL | N/A | Nov 10, 2015 |
| 5MG; 5MG; 5MG; 5MG | tablet | Discontinued | ORAL | N/A | Nov 10, 2015 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Discontinued | ORAL | N/A | Nov 10, 2015 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Discontinued | ORAL | N/A | Nov 10, 2015 |
22. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 22, 2019 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 22, 2019 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 22, 2019 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 22, 2019 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 22, 2019 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 22, 2019 |
23. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Discontinued | ORAL | N/A | Sep 30, 2003 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Discontinued | ORAL | N/A | Sep 30, 2003 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Discontinued | ORAL | N/A | Sep 30, 2003 |
| 5MG; 5MG; 5MG; 5MG | tablet | Discontinued | ORAL | N/A | Sep 30, 2003 |
24. USPHARMA WINDLAS
Uspharma Windlas Llc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Uspharma Windlas.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Apr 3, 2020 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Apr 3, 2020 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Apr 3, 2020 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Apr 3, 2020 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Apr 3, 2020 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Apr 3, 2020 |
25. BARR LABS INC
Barr Laboratories Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 12, 2013 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 12, 2013 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 12, 2013 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 12, 2013 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 12, 2013 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 12, 2013 |
26. EPIC PHARMA LLC
Epic Pharma Llc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Jun 19, 2002 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Jun 19, 2002 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Jun 19, 2002 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Jun 19, 2002 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Nov 3, 2014 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Nov 3, 2014 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Nov 3, 2014 |
27. ENDO OPERATIONS
Endo Operations Ltd has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Discontinued | ORAL | N/A | May 31, 2019 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Discontinued | ORAL | N/A | May 31, 2019 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Discontinued | ORAL | N/A | May 31, 2019 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Discontinued | ORAL | N/A | May 31, 2019 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Discontinued | ORAL | N/A | May 31, 2019 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Discontinued | ORAL | N/A | May 31, 2019 |
28. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | tablet | Prescription | ORAL | AB | Oct 6, 2023 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | tablet | Prescription | ORAL | AB | Oct 6, 2023 |
| 5MG; 5MG; 5MG; 5MG | tablet | Prescription | ORAL | AB | Oct 6, 2023 |
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | tablet | Prescription | ORAL | AB | Oct 6, 2023 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Oct 6, 2023 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Oct 6, 2023 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | tablet | Prescription | ORAL | AB | Oct 6, 2023 |
29. GRANULES
Granules Pharmaceuticals Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 23, 2023 |
| 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 23, 2023 |
| 1.875MG; 1.875MG; 1.875MG; 1.875MG | tablet | Prescription | ORAL | AB | Dec 28, 2021 |
| 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 23, 2023 |
| 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 23, 2023 |
| 5MG; 5MG; 5MG; 5MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 23, 2023 |
| 3.125MG; 3.125MG; 3.125MG; 3.125MG | tablet | Prescription | ORAL | AB | Dec 28, 2021 |
| 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Prescription | ORAL | AB1 | Jan 23, 2023 |